Nordea Investment Management
SLXP

Nordea Investment Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Nordea Investment Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,385
Closed -$239K – 971
2015
Q1 		$239K Hold
1,385
– – ﹤0.01% 705
2014
Q4 		$159K Buy
+1,385
New +$168K ﹤0.01% 736
2014
Q2 		– Sell
-12,000
Closed -$1.24M – 880
2014
Q1 		$1.24M Hold
12,000
– – 0.01% 518
2013
Q4 		$1.08M Hold
12,000
– – 0.01% 548
2013
Q3 		$803K Sell
12,000
-40,000
-77% -$2.76M ﹤0.01% 609
2013
Q2 		$3.44M Buy
+52,000
New +$2.97M 0.02% 327

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Nordea Investment Management's SLXP Position: Q2 2015 in Review

Nordea Investment Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,385 shares — an estimated $239K sold.

Nordea Investment Management first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $3.44M in Q2 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Nordea Investment Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Nordea Investment Management sold 1,385 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $239K.
  • Nordea Investment Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
  • Nordea Investment Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.44M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Nordea Investment Management's 13F filing for Q2 2015, filed 21 Jul 2015.